In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
battiste
Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
